We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to ...

Techno-optimist, investor and LinkedIn co-founder Reid Hoffman has written a new book, “Superagency,” outlining his vision of ...

In an interview with LinkedIn News' Jessi Hempel, the tech visionary will explain why he believes AI has the potential to ...

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

The LinkedIn founder talks about his new book, ‘Superagency,’ and argues that people can use AI to reshape their daily work lives.

Linkedin co-founder Reid Hoffman joins Morning Joe to discuss the new book 'Superagency: What Could Possibly Go Right with ...

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new ...

LinkedIn co-founder and AI investor Reid Hoffman argues we shouldn't be afraid of AI or its disruptive capabilities in his ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...